MGTA
Magenta Therapeutics Inc
Price:  
0.70 
USD
Volume:  
376,060.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MGTA WACC - Weighted Average Cost of Capital

The WACC of Magenta Therapeutics Inc (MGTA) is 8.8%.

The Cost of Equity of Magenta Therapeutics Inc (MGTA) is 13.90%.
The Cost of Debt of Magenta Therapeutics Inc (MGTA) is 5.00%.

Range Selected
Cost of equity 11.00% - 16.80% 13.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.4% - 10.2% 8.8%
WACC

MGTA WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 1.37 1.94
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.00% 16.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.4% 10.2%
Selected WACC 8.8%